NEOG’s Rosy Outlook Wilts: Margin Meltdown Revealed in Latest SEC Filing
Neogen’s Latest 8-K: Integration Hiccups and Margin Headaches 🤕 (June 4, 2025) Welcome back to your definitive guide to all things Neogen Corporation (NEOG), where...
Biotechnology Stocks
-
-
IRWD’s Delisting Dance: Can This Stock Tango Back From the Brink?
Ironwood Pharma (IRWD) Gets a Nasdaq Slap: Stock Price Limbo Below $1 📉 Welcome back to the ongoing saga of Ironwood Pharmaceuticals, Inc. (IRWD), where...
-
BCRX’s $450/hr Golden Parachute: What’s REALLY Behind Doyle’s Extended Stay?
BioCryst Extends CFO’s Consulting Gig: Smooth Transition or Golden Parachute 2.0? Welcome back to the ongoing saga of BioCryst Pharmaceuticals, Inc. (BCRX), where we dissect...
-
APDN’s 15-to-1 Reverse Split: Desperate Gambit or Last Stand? The SEC Filing Decoded.
APDN’s Reverse Stock Split: A Desperate Gamble to Stay on the Nasdaq? 🎲 Welcome back to the ongoing saga of Applied DNA Sciences, Inc. (APDN),...
-
MNMD’s Future Unlocks: What the New CFO’s $500k+ Pay REALLY Signals.
MindMed Gets a New Money Master: Brandi L. Roberts Takes the CFO Throne! Alright, finance fanatics, buckle up! This isn’t just another chapter in the...
-
AQB’s Fire Sale: Last Gasp or Strategic Pivot? SEC Filing Reveals All.
AquaBounty: Slim Pickings and a Whole Lotta Hope in Ohio AquaBounty Technologies, Inc. (AQB) filed an 8-K on May 15, 2025, and let’s just say...
-
ILMN Just Reloaded Its War Chest: Is This the Rocket Fuel for a Mega-Run?
Illumina Gets the Green Light: Stockholders Approve All Proposals, Including Juicy New Incentive Plan Illumina, Inc. (ILMN) recently filed an 8-K on May 22, 2025,...
-
VRTX Unleashes $4.7B Buyback Beast: Undervalued or Setting Up a Trap?
Vertex Flexes Financial Muscles with $4 Billion Share Buyback Vertex Pharmaceuticals Incorporated (VRTX) filed an 8-K on May 19, 2025, and we’re here to decode...
-
SDGR’s $30M Gamble: Will Slash and Burn Save Schrödinger or Scorch It?
Schrödinger Restructures, Swaps CFOs: A New Equation for Growth? Schrödinger, Inc. (SDGR) filed an 8-K on May 20, 2025, and it’s packed with news. Let’s...
-
PTPI’s Last Stand? Delisting Drama & the OTC Gamble (Must-Read SEC Intel)
Petros Pharmaceuticals (PTPI) Delisting: From Nasdaq to OTC – A Rocky Road Ahead? Petros Pharmaceuticals, Inc. (PTPI) dropped a bombshell 8-K filing on May 21,...
-
PRPH: Dumpster Fire or Diamond in the Rough? SEC Filing Hints at $50M Lifeline
ProPhase Labs Q1 2025: Cost-Cutting and Cash Scrambles – A Race Against the Clock? ProPhase Labs, Inc. (PRPH) filed its 10-Q on May 20, 2025,...
-
MNKD’s Future Unmasked: What the Fresh 8-K REALLY Says About Growth (and Risk).
MannKind Shareholders Give a Thumbs Up: Board, Compensation, and Auditors Approved MannKind Corporation (MNKD) recently filed an 8-K on May 19, 2025, detailing the happenings...